FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2025

The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:


			Basis of Fair Value Measurements

			Quoted Prices in Active Markets for Identical Assets/Liabilities		Significant Other Observable Inputs		Significant Unobservable Inputs
September 30, 2025	Total		Level 1		Level 2		Level 3
Assets:

Deferred compensation trading securities	$	82	$	82	$	—	$	—
Cash surrender value of life insurance policies	72		—		72		—
Equity investments	3		3		—		—


Fixed-to-variable interest rate swaps	18		—		18		—
Total	$	175	$	85	$	90	$	—

Liabilities:
Deferred compensation liabilities	$	152	$	—	$	152	$	—


Contingent consideration	114		—		—		114

Total	$	266	$	—	$	152	$	114

Redeemable noncontrolling interest	$	81	$	—	$	—	$	81


			Basis of Fair Value Measurements
December 31, 2024	Total		Level 1		Level 2		Level 3
Assets:
Deferred compensation trading securities	$	72	$	72	$	—	$	—
Cash surrender value of life insurance policies	64		—		64		—





Total	$	136	$	72	$	64	$	—

Liabilities:
Deferred compensation liabilities	$	140	$	—	$	140	$	—

Contingent consideration	106		—		—		106
Fixed-to-variable interest rate swaps	34		—		34		—


Total	$	280	$	—	$	174	$	106

Redeemable noncontrolling interest	$	83	$	—	$	—	$	83

The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):


	Contingent Consideration

Balance, December 31, 2024	$	106


Total fair value adjustments included in earnings - unrealized	8


Balance, September 30, 2025	$	114

QUEST DIAGNOSTICS INC 10-Q